PMS45 - COST PER RESPONDER ANALYSIS FOLLOWING A 48-WEEK...

Value in Health 2018 / 10 Vol. 21

PMS45 - COST PER RESPONDER ANALYSIS FOLLOWING A 48-WEEK PSORIATIC ARTHRITIS TREATMENT WITH SECUKINUMAB VERSUS ADALIMUMAB FROM THE PORTUGUESE PAYER PERSPECTIVE

Silva, C., Esparteiro, J., Fonseca, A., Laires, P.A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.09.1759
Date:
October, 2018
File:
PDF, 385 KB
2018
Conversion to is in progress
Conversion to is failed